Beruflich Dokumente
Kultur Dokumente
James Montier
Global Strategist
+44 207 762 5872
james.montier@sgcib.com
February 2009
Volatility: not unprecedented nor unpredictable
1
Not a Black Swan
2
Minsky/Kindleberger framework for bubbles
Displacement
Credit Creation
Euphoria
Revulsion
3
0
1
2
3
4
5
6
7
8
Jan-25
Jan-28
Jan-31
Jan-34
Jan-37
Jan-40
Jan-43
Jan-46
Jan-49
Jan-52
Jan-55
Jan-58
Jan-61
Jan-64
Jan-67
Jan-70
Jan-73
Jan-76
Jan-79
Jan-82
Jan-85
Debt is closer to revulsion (BAA spread)
Jan-88
Jan-91
Jan-94
Jan-97
Jan-00
Jan-03
Jan-06
4
Jan-09
10
20
30
40
50
60
0
1881
1885
1889
1894
1898
1903
1907
1911
1916
1920
1925
1929
1934
1938
1942
1947
1951
1956
1960
1964
Valuation - Graham and Dodd PE (US)
1969
1973
1978
1982
1987
1991
1995
2000
Source: SG Equity Research
2004
5
2009
Valuations determine long run returns (% p.a. real)
9
PE Range
6
10
15
20
25
30
35
0
5
Jan-37
Jan-40
Jan-43
Jan-46
Jan-49
Jan-52
Jan-55
Jan-58
Jan-61
Jan-64
Jan-67
Jan-70
UK Graham and Dodd PE
Jan-73
Jan-76
Jan-79
Jan-82
Jan-85
Jan-88
Jan-91
Jan-94
Jan-97
Jan-00
Jan-03
Jan-06
Jan-09
7
What would Ben think? (% passing)
EY>(2*AAA) 46 59 58 82 66
DY>2/3 of AAA 37 72 69 82 60
2 or fewer earnings 5 8 14 6 9
declines of -5%
8
Number of Stocks passing our Short criteria
(P/S>2, C score =5)
45
40 US
35
30
25
20
15
Europe
10
current
2005
2008
2003
2004
2002
2006
2007
2000
2001
1994
1995
1997
1998
1999
1996
9
Shareholder’s equity as % of total liabilities
70
60
50
40
30
20
10
0
Non-financials Banks
10
0.5
1.5
2.5
3.5
0
1
2
3
1927
1930
1933
1936
1939
1942
1945
1948
1951
1954
1957
1960
1963
1966
1969
1972
1975
1978
1981
Long-term US financials price to book
1984
1987
1990
1993
1996
1999
2002
2005
2008
11
Beware book value
1400
1200
Book value halved
1000
800
600
400
200
0
1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937
12
A bias against value? Does expensive wine taste better?
13
0.5
1.5
2.5
3.5
4.5
1
2
3
4
5
0
1950
1952
1955
1957
1960
1962
1965
1968
1970
1973
1975
1978
1981
The earnings cycle – S&P500
1983
1986
1988
1991
1993
1996
1999
2001
2004
2006
14
10
20
30
40
50
60
70
80
90
1997
1998
1998
1999
1999
2000
2001
2001
2002
2002
2003
2003
2004
2005
2005
What if the 1930’s repeated? (S&P500)
2006
2006
2007
2008
2009
2009
2009
2010
was to
2010
hold today
experience
If the 1930s
2011
15
Why buy value? Protection against error and poor
outcomes
16
Indiscriminate selling – Performance across G&D PE
deciles (%) 2008
Value 2 3 4 5 6 7 8 9 Glamour
0
-5
-10
-15
-20
-25
-30
-35
-40
-45
-50
17
Value in the Great Depression (% p.a.)
Value Growth Market
0.0
-5.0
-10.0
-15.0
-20.0
-25.0
-30.0
-35.0
-40.0 B/P
D/Y
-45.0
18
The dark side of emotion: the psychology of bear markets
90
80
70
60
50
40
30
20
10
0
No invest Invest and lost Invest and won
19
No sign of learning: the longer it lasts, the worse we get
90
85
80
75
70
65
60
55
50
45
40
20
Equities are a long duration asset – contribution to value
from… (%)
80
70
60
50
40
30
20
10
21
ADHD and stock holding periods
10
1920 1925 1930 1935 1940 1945 1950 1955 1960 1965 1970 1975 1980 1985 1990 1995 2000 2005
Source: NYSE
22
Contributions to total real returns
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
1 year time horizon 5 year time horizon
23
0
0.5
1.5
2.5
3.5
4.5
1
2
3
4
Sep-00
Jan-01
May-01
Sep-01
Jan-02
May-02
Sep-02
Jan-03
May-03
Sep-03
Jan-04
May-04
Sep-04
Jan-05
May-05
Sep-05
Jan-06
May-06
Sep-06
Jan-07
May-07
Sep-07
Sources of cheap insurance (Index linked yields TIPS)
Jan-08
May-08
Sep-08
Jan-09
24
Gold
1050
1000
950
900
850
800
750
700
650
600
F M A M J J A S O N D J F M A M J J A S O N D J
25
Dividend swaps
World dividends discounts- 2008 = basis 100
100
90
80
70
60
50
40
30
20
STOX5E_X SP500 US great depression
10
0
2011
2012
2014
2013
2010
2015
2008
2009
Year
26
Top decile fund managers – Performance in...
0
-2
-4
-6
-8
-10
-12
-14
-16
-18
-20
Worst 1 year Worst 3-years
Source: Brandes Institute
27
Percentage of long-term top performers in lower
performance deciles
100
80
60
40
20
0
Decile 6 Decile 7 Decile 8 Decile 9 Decile 10
28
Performance around hiring and firing decisions
15
(%)
10 Hired
Fired
-5
-10 -3 to 0 -2 to 0 -1 to 0 0 0 to 1 0 to 2 0 to 3
IMPORTANT DISCLAIMER: The information herein is not intended to be an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities and including any expression of opinion,
has been obtained from or is based upon sources believed to be reliable but is not guaranteed as to accuracy or completeness although Société Générale (“SG”) believe it to be clear, fair and
not misleading. SG, and their affiliated companies in the SG Group, may from time to time deal in, profit from the trading of, hold or act as market-makers or act as advisers, brokers or
bankers in relation to the securities, or derivatives thereof, of persons, firms or entities mentioned in this document or be represented on the board of such persons, firms or entities.
Employees of SG, and their affiliated companies in the SG Group, or individuals connected to then, other than the authors of this report, may from time to time have a position in or be holding
any of the investments or related investments mentioned in this document. Each author of this report is not permitted to trade in or hold any of the investments or related investments which are
the subject of this document. SG and their affiliated companies in the SG Group are under no obligation to disclose or take account of this document when advising or dealing with or for their
customers. The views of SG reflected in this document may change without notice. To the maximum extent possible at law, SG does not accept any liability whatsoever arising from the use of
the material or information contained herein. This research document is not intended for use by or targeted at private customers. Should a private customer obtain a copy of this report they
should not base their investment decisions solely on the basis of this document but must seek independent financial advice.
Important notice: The circumstances in which materials provided by SG Fixed & Forex Research, SG Commodity Research, SG Convertible Research, SG Technical Research and SG Equity
Derivatives Research have been produced are such (for example because of reporting or remuneration structures or the physical location of the author of the material) that it is not appropriate
to characterise it as independent investment rese arch as referred to in European MIF directive and that it should be treated as a marketing material even if it contains a research
recommendation (« recommandation d’investissement à caractère promotionnel »). However, it must be made clear that all publications issued by SG will be clear, fair, and not misleading.
Analyst Certification: Each author of this research report hereby certifies that (i) the views expressed in the research report accurately reflect his or her personal views about any and all of
the subject securities or issuers and (ii) no part of his or her compensation was, is, or will be related, directly or indirectly, to the specific recommendations or views expressed in this report.
Notice to French Investors: This publication is issued in France by or through Société Générale ("SG") which is regulated by the AMF (Autorité des Marchés Financiers).
Notice to UK investors: This publication is issued in the United Kingdom by or through Société Générale ("SG") London Branch which is authorised and regulated by the Financial Services
Authority ("FSA") for the conduct of its UK business.
Notice To US Investors: This report is intended only for major US institutional investors pursuant to SEC Rule 15a-6. Any US person wishing to discuss this report or effect transactions in any
security discussed herein should do so with or through SG Americas Securities, LLC (“SGAS”) 1221 Avenue of the Americas, New York, NY 10020. (212)-278-6000. THIS RESEARCH
REPORT IS PRODUCED BY SOCIETE GENERALE AND NOT SGAS.
Notice to Japanese Investors: This report is distributed in Japan by Société Générale Securities (North Pacific) Ltd., Tokyo Branch, which is regulated by the Financial Services Agency of
Japan. The products mentioned in this report may not be eligible for sale in Japan and they may not be suitable for all types of investors.
Notice to Australian Investors: Société Générale Australia Branch (ABN 71 092 516 286) (SG) takes responsibility for publishing this document. SG holds an AFSL no. 236651 issued under
the Corporations Act 2001 (Cth) ("Act"). The information contained in this newsletter is only directed to recipients who are wholesale clients as defined under the Act.
US THIRD PARTY FOREIGN AFFILIATE RESEARCH DISCLOSURES:
The subject company of this research report currently is, or was during the 12-month period preceding the date of distribution of this report, a client of SG or its affiliates.
SG or its affiliates has received compensation for investment banking services from the subject company of this research report in the past 12 months.
SG or its affiliates expects to receive or intends to seek compensation for investment banking services from the subject company of this research report in the next 3 months.
SG or its affiliates acts as a market maker or liquidity provider in the equities securities that are subject of this research report.
IMPORTANT DISCLOSURES: Please refer to our website: http:\\www.sgresearch.socgen.com
http://www.sgcib.com. Copyright: The Société Générale Group 2008. All rights reserved.
30